Elvanse

Elvanse is a brand name for lisdexamfetamine dimesylate, a central nervous system stimulant medication. It is primarily prescribed for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in children and adults. Elvanse works by increasing the levels of certain neurotransmitters in the brain, namely dopamine and norepinephrine, which are thought to play a role in regulating attention and behavior.

The active ingredient, lisdexamfetamine, is a prodrug. This means it is inactive until it is metabolized by the body. After oral administration, lisdexamfetamine is converted into dextroamphetamine, the active form. This prodrug mechanism is designed to provide a smoother, more sustained release of the medication throughout the day, potentially reducing the risk of abuse and dependence compared to immediate-release amphetamines.

Elvanse is typically taken once daily as a capsule. Dosage is individualized and adjusted based on the patient's response and tolerability. Common side effects can include decreased appetite, insomnia, dry mouth, and irritability. More serious side effects, though less common, may include cardiovascular issues and psychiatric symptoms. It is important for patients to be monitored by a healthcare professional while taking Elvanse. The medication is a controlled substance due to its potential for abuse and should be used strictly as prescribed.